Plasma GFAP in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.
O'Connor, A
; Abel, E; Benedet, AL; Poole, T; Ashton, N; Weston, PSJ; Heslegrave, AJ; Ryan, N; Barker, S; Polke, JM; +3 more...Blennow, K; Zetterberg, H; Fox, NC and
(2022)
Plasma GFAP in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.
Journal of Neurology, Neurosurgery, and Psychiatry, 94 (1).
pp. 90-92.
DOI: 10.1136/jnnp-2022-329663
; Abel, E; Benedet, AL; Poole, T; Ashton, N; Weston, PSJ; Heslegrave, AJ; Ryan, N; Barker, S; Polke, JM; +3 more...Blennow, K; Zetterberg, H; Fox, NC and
(2022)
Plasma GFAP in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.
Journal of Neurology, Neurosurgery, and Psychiatry, 94 (1).
pp. 90-92.
DOI: 10.1136/jnnp-2022-329663
-
picture_as_pdf - OConnor_etal_2022_Plasma-GFAP-in-presymptomatic-and-symptomatic.pdf
-
subject - Accepted Version
-
error - This is an author accepted manuscript version of an article accepted for publication, and following peer review. Please be aware that minor differences may exist between this version and the final version if you wish to cite from it.
-
- Available under Creative Commons: Attribution-NonCommercial 4.0
Downloads